Blue Horseshoe Stocks: More Big Wins, Bottom-Play

Friday’s Big Wins

We continue to pepper our readers’ inboxes with options ideas almost every day, and Friday’s report was no different. We featured a pair of fresh ideas in the ROKU and TTD chains, and hit the nail on the head with both of them to close out another solid week with strength!

The following single-session gain opportunities were there for the taking after both stocks had productive sessions on the heels of their earnings reports. TTD and ROKU took the 3rd and 6th top gainer spots, respectively, for the whole of the NASDAQ on Friday.  Out of eight sets of contracts, all eight recorded multi-bag runs on the day, with the ROKU moves being considerably more impressive. 

Roku, Inc. ROKU Weekly $53-56 Calls

$53 Calls – Range: 2.42-11.89 – Max Gain: 391%
$53.50 Calls – Range: 1.90-11.00 – Max Gain: 479%
$54 Calls – Range: 1.65-10.86 – Max Gain: 558%
$54.50 Calls – Range: 1.27-9.87 – Max Gain: 677%
$55 Calls – Range: 1.12-9.95 – Max Gain: 788%
$56 Calls – Range: .75-8.84 – Max Gain: 1079%
______

The Trade Desk Inc. TTD Weekly $170-175 Calls
$170 Calls – Range: 9.65-27.37 – Max Gain: 184%
$175 Calls – Range: 4.60-26.00 – Max Gain: 465%


Fresh Options Idea:
SPDR S&P500 ETF (SPY) 02/25 279.50-281 Calls*

* These options expire at the end of today’s session. Do not attempt to trade unless you are an advanced level trader with access to disposable funds.


Extended Watchlist:
ABEO, YRIV, NTLA, TTNP, BMRN, LX, NIO, PIR, SOGO, INSG, ARWR, SOLO, UNIT (Bottom-Watch)

Blue Horseshoe Stocks: NBEV Recap & More

New Age Beverages Inc. NBEV

Our first order of business this morning is to rehash the performance of NBEV this week, subsequent to our initial alert on the play on Tuesday morning. It was enough of a heads-up to catch the stock at its weekly low of 1.53, which has given way to new highs after a pair of very strong outings.

Yesterday NBEV reached a new high of 2.40, which marks a two-session swing amounting to a respectable 57% We’ll be sure to continue to monitor the situation in the event that the stock parlays its strong start to the short week into an equally convincing finish.

Despite then closing below, the stock has been rebolstered in the premarket, having already traded back as high as yesterday’s peak at 2.40. If this stock can break through the channel of resistance between 2.40-2.58, we could see some more very interesting activity from this play.



Fresh Options Ideas:

We’ve got an earnings related options idea with GIII this morning, and are also taking note of the chart setups on FB and TWTR, which are presently exhibiting double bottom formations as they search for solid support. Each also has a gap to the upside, so we’re going to signal some extended term ideas to track.

GIII 09/21 $45 & 50
FB 10/12 $182.50-190 Calls
TWTR 10/12 $35-37.50 Calls


Extended Watchlist:
ARWR, SPPI, MYSZ, RSLS, SBOT, OBLN, PDS

Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.


InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)


Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,